Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021 to detail how its system, which combines A.I. technology, machine learning, hardware, software — and yes, lasers! — could eventually democratize access to cell therapies. It aims to bring down costs associated with the manufacturing of human cells, […]